U.S. federal trademark · Serial No. 88826511 · Reg. No. 6198835
Providing a biotechnology platform for oligonucleotide-based therapeutics, namely, providing scientific research and development, to enable drug developers to enhance delivery and bioactivity of oligonucleotide-based therapeutics
Providing intellectual property licensing in the field of oligonucleotide-based therapies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.